Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use

Recent studies have found that cannabinoids may improve neuropsychological performance, ameliorate negative symptoms, and have antipsychotic properties for a subgroup of the schizophrenia population. These findings are in contrast to the longstanding history of adverse consequences of cannabis use,...

Descripción completa

Detalles Bibliográficos
Autores principales: Coulston, Carissa M., Perdices, Michael, Henderson, Antony F., Malhi, Gin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428612/
https://www.ncbi.nlm.nih.gov/pubmed/22937266
http://dx.doi.org/10.1155/2011/501726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428612/
https://www.ncbi.nlm.nih.gov/pubmed/22937266
http://dx.doi.org/10.1155/2011/501726

Ejemplares similares